Keyphrases
Breast Cancer Progression
67%
Breast Cancer
51%
Overall Survival
48%
Metastasis
36%
Progression-free Survival
33%
Protein C-termini
32%
Prostate Cancer
32%
Transforming Growth Factor-β
32%
Growth Factor Signaling
32%
Interacting Proteins
32%
Oncologists
32%
Stereotactic Body Radiotherapy
32%
K-ATPase
32%
TGF-β Receptor
32%
Functional Expression
32%
Non-radiation
32%
Transforming Growth Factor Receptor
32%
Adenosine Triphosphatase
32%
Tumor Repopulation
32%
Nischarin
32%
Peripheral Node Addressin
32%
18F-fluorothymidine
32%
Ki-67
32%
Sulfotransferase
32%
High Endothelial Venules
32%
Nude Mice
32%
Lymphoid Organs
32%
FaDu
32%
Neogenesis
32%
Fractionated Radiotherapy
32%
Squamous Cell Carcinoma (SqCC)
32%
Locally Recurrent
32%
Ablative Radiotherapy
32%
Metastatic Rectal Cancer
32%
Distant Progression
32%
Long-term Survival
32%
Multi-institutional
32%
Pooled Analysis
32%
Re-irradiation
32%
Oligometastatic Patients
32%
Tumor Suppression
32%
Molecular Characterization
32%
Cytoplasmic Domain
25%
Human Breast Cancer
25%
18F-FLT
24%
Extracranial
19%
Cancer Lung
16%
Lung Cancer
16%
Tumor Angiogenesis
16%
Tumor Invasion
16%
Medicine and Dentistry
Breast Cancer
100%
Metastatic Carcinoma
58%
Overall Survival
51%
Progression Free Survival
44%
Neoplasm
40%
Cancer Growth
38%
Radiation Therapy
38%
Prostate Cancer
35%
Lung Cancer
32%
Carboxy Terminal Sequence
32%
Long Term Survival
32%
Rectum Cancer
32%
Pooled Analysis
32%
Growth Factor Receptor
32%
Stereotactic Body Radiation Therapy
32%
Oncologist
32%
Re-Irradiation
32%
Protein C
32%
Cancer Growth Factor
32%
Integrin
32%
Cancer Cell
24%
Primary Tumor
22%
Focal Adhesion Kinase
19%
Tumor Progression
19%
Janus Kinase 1
19%
Diseases
18%
Heterozygosity
12%
Short Hairpin RNA
12%
MCF-7
12%
Xenograft
12%
Tumor Suppressor Protein
12%
Cell Invasion
11%
Liver Cancer
8%
Treatment Planning
8%
Drug Megadose
8%
Treatment of Lung Cancer
8%
Patient Positioning
8%
Ionizing Radiation
8%
Tumor Xenograft
6%
Intraoperative Radiation Therapy
6%
Recurrent Disease
6%
Metastatic Breast Cancer
6%
Real-Time Polymerase Chain Reaction
6%
Breast Tissue
6%
Microsatellite Marker
6%
Breast Tumor
6%
Immunohistochemistry
6%
Survival Time
6%
Intensity Modulated Radiation Therapy
6%
Messenger RNA
6%
